{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:38:24Z","timestamp":1782513504178,"version":"3.54.5"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016120","name":"Departamento de Salud, Gobierno de Navarra","doi-asserted-by":"publisher","award":["Project-43"],"award-info":[{"award-number":["Project-43"]}],"id":[{"id":"10.13039\/501100016120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016120","name":"Departamento de Salud, Gobierno de Navarra","doi-asserted-by":"publisher","award":["2019 modality A"],"award-info":[{"award-number":["2019 modality A"]}],"id":[{"id":"10.13039\/501100016120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023315","name":"Asociaci\u00f3n de Amigos de la Universidad de Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Miguel Servet CPII20\/00027"],"award-info":[{"award-number":["Miguel Servet CPII20\/00027"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","award":["FPU20\/01671"],"award-info":[{"award-number":["FPU20\/01671"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004435","name":"Universidad de Navarra","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Ochratoxin A (OTA) is a mycotoxin produced by <jats:italic>Aspergillus<\/jats:italic> and <jats:italic>Penicillium<\/jats:italic> species that contaminates various food and feed products, presenting potential risks to human health. While OTA is well-known for its nephrotoxic effects, emerging evidence highlights its neurotoxic potential. Parkinson\u2019s disease (PD) is a neurodegenerative disorder with both genetic and environmental aetiologies. Emerging lines of investigation have focused their research on the role of environmental toxins, including mycotoxins, in PD pathogenesis. However, the specific involvement of OTA in PD-related pathways still needs to be unravelled. This systematic review compiles and evaluates OTA neurotoxicity studies according to the adverse outcome pathway (AOP) for PD, established by the Organisation for Economic Cooperation and Development (OECD). The AOP framework outlines a series of key event (KEs) beginning with mitochondrial Complex I (CI) inhibition and progressing through mitochondrial dysfunction, impaired proteostasis, dopaminergic neuron degeneration, neuroinflammation, and resulting in parkinsonian motor deficits. In this systematic review, a comprehensive literature search was conducted in PubMed, to identify studies evaluating OTA neurotoxic effects. Using a search strategy of 19 terms and following a two-phased study selection, 30 relevant studies were retrieved, of which 16 dealt with in vitro adult neurotoxicity (ANT), 13 focused on in vivo ANT, and 1 gave both in vitro and in vivo approaches. Authors agree that in vitro and in vivo exposure to OTA causes mitochondrial dysfunction, impaired proteostasis, degeneration of dopaminergic (DA) neurons, and neuroinflammation. However, a notable absence of research\u00a0remains on the molecular initiating event (MIE), binding to CI, and on\u00a0KE1, inhibition of CI. This review identifies critical research gaps and highlights the need for further mechanistic studies on the impact of OTA on neurodegenerative pathways, particularly its binding and inhibition of CI, as well as mechanisms related to KE3: impaired proteostasis. Addressing these gaps may provide valuable insights into OTA neurotoxic potential and its relevance in PD-like neurodegeneration.<\/jats:p>","DOI":"10.1007\/s00204-025-03994-5","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T04:03:31Z","timestamp":1741233811000},"page":"1769-1790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Potential role of ochratoxin A in Parkinson\u2019s disease: a systematic review of current evidence"],"prefix":"10.1007","volume":"99","author":[{"given":"M.","family":"Serrano-Civantos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Beraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"\u00c1lvarez-Erviti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L\u00f3pez","family":"de Cerain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9182-8417","authenticated-orcid":false,"given":"A.","family":"Vettorazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"3994_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121\u2013126. https:\/\/doi.org\/10.1016\/S0076-6879(84)05016-3","journal-title":"Methods Enzymol"},{"issue":"1","key":"3994_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12550-019-00370-y","volume":"36","author":"N Babayan","year":"2020","unstructured":"Babayan N, Tadevosyan G, Khondkaryan L, Grigoryan R, Sarkisyan N, Haroutiounian R, Stopper H (2020) Ochratoxin A induces global DNA hypomethylation and oxidative stress in neuronal cells in vitro. Mycotoxin Res 36(1):73\u201381. https:\/\/doi.org\/10.1007\/s12550-019-00370-y","journal-title":"Mycotoxin Res"},{"issue":"4","key":"3994_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1079\/bjn20041092","volume":"91","author":"A Baldi","year":"2004","unstructured":"Baldi A, Losio MN, Cheli F, Rebucci R, Sangalli L, Fusi E, Bertasi B, Pavoni E, Carli S, Politis I (2004) Evaluation of the protective effects of \u03b1-tocopherol and retinol against ochratoxin A cytotoxicity. Br J Nutr 91(4):507\u2013512. https:\/\/doi.org\/10.1079\/bjn20041092","journal-title":"Br J Nutr"},{"key":"3994_CR4","doi-asserted-by":"publisher","unstructured":"Bal-Price A, Leist M, Schildknecht S, Tschudi-Monnet F, Paini A, Terron A (2018) Adverse outcome pathway on inhibition of the mitochondrial complex I of nigro-striatal neurons leading to parkinsonian motor deficits. OECD Series on Adverse Outcome Pathways, No. 7, OECD Publishing, Paris. https:\/\/doi.org\/10.1787\/b46c3c00-en","DOI":"10.1787\/b46c3c00-en"},{"issue":"5","key":"3994_CR75","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/toxins13050327","volume":"13","author":"M Behrens","year":"2021","unstructured":"Behrens M, H\u00fcwel S, Galla HJ, Humpf HU (2021) Efflux at the blood-brain barrier reduces the cerebral exposure to ochratoxin A, ochratoxin \u03b1, citrinin and dihydrocitrinone. Toxins 13(5):327. https:\/\/doi.org\/10.3390\/toxins13050327","journal-title":"Toxins"},{"issue":"7","key":"3994_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1177\/096032719801700704","volume":"17","author":"A Belmadani","year":"1998","unstructured":"Belmadani A, Tramu G, Betbeder AM, Creppy EE (1998a) Subchronic effects of ochratoxin A on young adult rat brain and partial prevention by aspartame, a sweetener. Hum Exp Toxicol 17(7):380\u2013386. https:\/\/doi.org\/10.1177\/096032719801700704","journal-title":"Hum Exp Toxicol"},{"issue":"10","key":"3994_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s002040050557","volume":"72","author":"A Belmadani","year":"1998","unstructured":"Belmadani A, Tramu G, Betbeder AM, Steyn PS, Creppy EE (1998b) Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain. Arch Toxicol 72(10):656\u2013662. https:\/\/doi.org\/10.1007\/s002040050557","journal-title":"Arch Toxicol"},{"issue":"2","key":"3994_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s002040050594","volume":"73","author":"A Belmadani","year":"1999","unstructured":"Belmadani A, Steyn PS, Tramu G, Betbeder AM, Baudrimont I, Creppy EE (1999) Selective toxicity of ochratoxin a in primary cultures from different brain regions. Arch Toxicol 73(2):108\u2013114. https:\/\/doi.org\/10.1007\/s002040050594","journal-title":"Arch Toxicol"},{"issue":"3","key":"3994_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1128\/CMR.16.3.497-516.2003","volume":"16","author":"JW Bennett","year":"2003","unstructured":"Bennett JW, Klich M (2003) Mycotoxins. Clin Microbiol Rev 16(3):497\u2013516. https:\/\/doi.org\/10.1128\/CMR.16.3.497-516.2003","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"3994_CR70","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/foods13081184","volume":"13","author":"Y Ben Miri","year":"2024","unstructured":"Ben Miri Y, Benabdallah A, Chentir I, Djenane D, Luvisi A, De Bellis L (2024) Comprehensive insights into ochratoxin A: occurrence, analysis, and control strategies. Foods (Basel, Switzerland) 13(8):1184. https:\/\/doi.org\/10.3390\/foods13081184","journal-title":"Foods (Basel, Switzerland)"},{"issue":"5","key":"3994_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/toxins16050213","volume":"16","author":"E Beraza","year":"2024","unstructured":"Beraza E, Serrano-Civantos M, Izco M, Alvarez-Erviti L, Gonzalez-Pe\u00f1as E, Vettorazzi A (2024) High-performance liquid chromatography-fluorescence detection method for Ochratoxin A quantification in small mice sample volumes: versatile application across diverse matrices relevant for neurodegeneration research. Toxins 16(5):213. https:\/\/doi.org\/10.3390\/toxins16050213","journal-title":"Toxins"},{"key":"3994_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2016.01142","volume":"7","author":"PV Bhat","year":"2016","unstructured":"Bhat PV, Pandareesh MD, Khanum F, Tamatam A (2016) Cytotoxic effects of ochratoxin a in Neuro-2a cells: role of oxidative stress evidenced by N-acetylcysteine. Front Microbiol 7:1\u201312. https:\/\/doi.org\/10.3389\/fmicb.2016.01142","journal-title":"Front Microbiol"},{"key":"3994_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuint.2018.04.003","volume":"118","author":"PV Bhat","year":"2018","unstructured":"Bhat PV, Anand T, Mohan Manu T, Khanum F (2018) Restorative effect of L-Dopa treatment against Ochratoxin A induced neurotoxicity. Neurochem Int 118:252\u2013263. https:\/\/doi.org\/10.1016\/j.neuint.2018.04.003","journal-title":"Neurochem Int"},{"key":"3994_CR12","volume-title":"Neuroanatomy and pathology of sporadic Parkinson\u2019s disease","author":"H Braak","year":"2008","unstructured":"Braak H, Del Tredici K (2008) Neuroanatomy and pathology of sporadic Parkinson\u2019s disease, vol 201. Springer, Berlin Heidelberg"},{"key":"3994_CR13","doi-asserted-by":"publisher","unstructured":"Carlberg, I., & Mannervik, B. (1985). Glutathione reductase. In Methods in Enzymology, (Vol. 113, pp. 484\u2013490). Elsevier. https:\/\/doi.org\/10.1016\/S0076-6879(85)13062-4","DOI":"10.1016\/S0076-6879(85)13062-4"},{"issue":"1","key":"3994_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1515\/bmc-2022-0017","volume":"13","author":"A Chansawhang","year":"2022","unstructured":"Chansawhang A, Phochantachinda S, Temviriyanukul P, Chantong B (2022) Corticosterone potentiates ochratoxin A-induced microglial activation. Biomol Concepts 13(1):230\u2013241. https:\/\/doi.org\/10.1515\/bmc-2022-0017","journal-title":"Biomol Concepts"},{"issue":"9","key":"3994_CR15","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/jat.4652","volume":"44","author":"C Chu","year":"2024","unstructured":"Chu C, Chen Y, Liang W (2024) Investigation of the mechanisms behind ochratoxin A-induced cytotoxicity in human astrocytes and the protective effects of N -acetylcysteine. J Appl Toxicol 44(9):1454\u20131465. https:\/\/doi.org\/10.1002\/jat.4652","journal-title":"J Appl Toxicol"},{"issue":"4","key":"3994_CR16","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/j.1471-4159.1972.tb01431.x","volume":"19","author":"JT Coyle","year":"1972","unstructured":"Coyle JT, Axelrod J (1972) Tyrosine hydroxylase in rat brain: developmental characteristics. J Neurochem 19(4):1117\u20131123. https:\/\/doi.org\/10.1111\/j.1471-4159.1972.tb01431.x","journal-title":"J Neurochem"},{"key":"3994_CR18","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"issue":"1","key":"3994_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(93)90175-F","volume":"52","author":"P Damier","year":"1993","unstructured":"Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F (1993) Glutathione peroxidase, glial cells and Parkinson\u2019s disease. Neuroscience 52(1):1\u20136. https:\/\/doi.org\/10.1016\/0306-4522(93)90175-F","journal-title":"Neuroscience"},{"issue":"2","key":"3994_CR20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0005-2728(98)00029-2","volume":"1364","author":"M Degli Esposti","year":"1998","unstructured":"Degli Esposti M (1998) Inhibitors of NADH\u2013ubiquinone reductase: an overview. Biochim Biophys Acta 1364(2):222\u2013235. https:\/\/doi.org\/10.1016\/S0005-2728(98)00029-2","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"3994_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1191\/0960327103ht357oa","volume":"22","author":"N Delibas","year":"2003","unstructured":"Delibas N, Altuntas I, Yonden Z, Ozcelik N (2003) Ochratoxin A reduces NMDA receptor subunits 2A and 2B concentrations in rat hippocampus: partial protective effect of melatonin. Hum Exp Toxicol 22(6):335\u2013339. https:\/\/doi.org\/10.1191\/0960327103ht357oa","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"3994_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0278-6915(00)00107-1","volume":"39","author":"PM Dortant","year":"2001","unstructured":"Dortant PM, Peters-Volleberg GWM, Van Loveren H, Marquardt RR, Speijers GJA (2001) Age-related differences in the toxicity of ochratoxin A in female rats. Food Chem Toxicol 39(1):55\u201365. https:\/\/doi.org\/10.1016\/S0278-6915(00)00107-1","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"3994_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molbrainres.2004.09.011","volume":"134","author":"M Ebadi","year":"2005","unstructured":"Ebadi M, Brown-Borg H, El Refaey H, Singh BB, Garrett S, Shavali S, Sharma SK (2005) Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson\u2019s disease. Mol Brain Res 134(1):67\u201375. https:\/\/doi.org\/10.1016\/j.molbrainres.2004.09.011","journal-title":"Mol Brain Res"},{"issue":"6","key":"3994_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2903\/j.efsa.2006.365","volume":"4","author":"EFSA Contam Panel (EFSA Panel on Contaminants in the Food Chain)","year":"2006","unstructured":"EFSA Contam Panel (EFSA Panel on Contaminants in the Food Chain) (2006) Opinion of the Scientific Panel on contaminants in the food chain [CONTAM] related to ochratoxin A in food. EFSA J 4(6):365. https:\/\/doi.org\/10.2903\/j.efsa.2006.365","journal-title":"EFSA J"},{"issue":"5","key":"3994_CR25","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.2903\/j.efsa.2020.6113","volume":"18","author":"D Schrenk","year":"2020","unstructured":"EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain), Schrenk D, Bodin L, Chipman JK, del Mazo J, Grasl-Kraupp B, Hogstrand C, Hoogenboom L, Leblanc JC, Nebbia CS, Nielsen E, Ntzani E, Petersen A, Sand S, Schwerdtle T, Vleminckx C, Wallace H, Alexander J, Dallsta C, Mally A, Metzler M, Binaglia M, Horv\u00e1th Z, Steinkellner H, Bignami M (2020) Risk assessment of ochratoxin A in food. EFSA J 18(5):6113. https:\/\/doi.org\/10.2903\/j.efsa.2020.6113","journal-title":"EFSA J"},{"issue":"1","key":"3994_CR73","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neurol.2015.09.012","volume":"172","author":"A Elbaz","year":"2016","unstructured":"Elbaz A, Carcaillon L, Kab S, Moisan F (2016) Epidemiology of Parkinson\u2019s disease. Revue Neurol 172(1):14\u201326. https:\/\/doi.org\/10.1016\/j.neurol.2015.09.012","journal-title":"Revue Neurol"},{"issue":"7","key":"3994_CR26","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.chemosphere.2009.01.049","volume":"75","author":"YS El-Sayed","year":"2009","unstructured":"El-Sayed YS, Khalil RH, Saad TT (2009) Acute toxicity of ochratoxin-A in marine water-reared sea bass (Dicentrarchus labrax L.). Chemosphere 75(7):878\u2013882. https:\/\/doi.org\/10.1016\/j.chemosphere.2009.01.049","journal-title":"Chemosphere"},{"issue":"2","key":"3994_CR27","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/0003-2697(76)90488-7","volume":"70","author":"EF Elstner","year":"1976","unstructured":"Elstner EF, Heupel A (1976) Inhibition of nitrite formation from hydroxylammoniumchloride: a simple assay for superoxide dismutase. Anal Biochem 70(2):616\u2013620. https:\/\/doi.org\/10.1016\/0003-2697(76)90488-7","journal-title":"Anal Biochem"},{"key":"3994_CR28","unstructured":"European Commission (2023) Commission Regulation (EU) 2023\/915 of 25 April 2023 on\u00a0maximum levels for certain contaminants in food and repealing Regulation (EC) No 1881\/2006\u00a0(Text with EEA relevance).\u00a0Official Journal of the European Union,\u00a0L 119, 103\u2013158. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=OJ:L:2023:119:FULL"},{"issue":"1","key":"3994_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s10792-024-03032-w","volume":"44","author":"M Fu","year":"2024","unstructured":"Fu M, Chen Y, Yang A (2024) Ochratoxin A induces mitochondrial dysfunction, oxidative stress, and apoptosis of retinal ganglion cells (RGCs), leading to retinal damage in mice. Int Ophthalmol 44(1):72. https:\/\/doi.org\/10.1007\/s10792-024-03032-w","journal-title":"Int Ophthalmol"},{"issue":"10","key":"3994_CR30","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.3390\/toxins7104253","volume":"7","author":"AH Heussner","year":"2015","unstructured":"Heussner AH, Bingle LEH (2015) Comparative ochratoxin toxicity: a review of the available data. Toxins 7(10):4253\u20134282. https:\/\/doi.org\/10.3390\/toxins7104253","journal-title":"Toxins"},{"key":"3994_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2021.112164","volume":"152","author":"M Izco","year":"2021","unstructured":"Izco M, Vettorazzi A, Forcen R, Blesa J, de Toro M, Alvarez-Herrera N, Cooper JM, Gonzalez-Pe\u00f1as E, Lopez de Cerain A, Alvarez-Erviti L (2021) Oral subchronic exposure to the mycotoxin ochratoxin A induces key pathological features of Parkinson\u2019s disease in mice six months after the end of the treatment. Food Chem Toxicol 152:112164. https:\/\/doi.org\/10.1016\/j.fct.2021.112164","journal-title":"Food Chem Toxicol"},{"issue":"10","key":"3994_CR32","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.biocel.2004.02.023","volume":"36","author":"KR Jessen","year":"2004","unstructured":"Jessen KR (2004) Glial cells. Int J Biochem Cell Biol 36(10):1861\u20131867. https:\/\/doi.org\/10.1016\/j.biocel.2004.02.023","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"3994_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000136485","volume":"11","author":"D Jollow","year":"1974","unstructured":"Jollow D, Mitchell JR, Zampaglione N, Gillette JR (1974) Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11(3):151\u2013169. https:\/\/doi.org\/10.1159\/000136485","journal-title":"Pharmacology"},{"issue":"20","key":"3994_CR35","doi-asserted-by":"publisher","first-page":"11237","DOI":"10.3390\/ijms222011237","volume":"22","author":"CS Khoi","year":"2021","unstructured":"Khoi CS, Chen JH, Lin TY, Chiang CK, Hung KY (2021) Ochratoxin A-induced nephrotoxicity: Up-to-date evidence. Int J Molecular Sci 22(20):11237. https:\/\/doi.org\/10.3390\/ijms222011237","journal-title":"Int J Molecular Sci"},{"issue":"43","key":"3994_CR36","doi-asserted-by":"publisher","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","volume":"29","author":"KA Kigerl","year":"2009","unstructured":"Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29(43):13435\u201313444. https:\/\/doi.org\/10.1523\/JNEUROSCI.3257-09.2009","journal-title":"J Neurosci"},{"issue":"4","key":"3994_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/toxins8040111","volume":"8","author":"T K\u0151szegi","year":"2016","unstructured":"K\u0151szegi T, Po\u00f3r M (2016) Ochratoxin A: molecular interactions, mechanisms of toxicity and prevention at the molecular level. Toxins 8(4):111. https:\/\/doi.org\/10.3390\/toxins8040111","journal-title":"Toxins"},{"issue":"2","key":"3994_CR39","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4014\/jmb.1610.10053","volume":"27","author":"HW Lee","year":"2017","unstructured":"Lee HW, Kim YJ, Nam SJ, Kim H (2017) Potent selective inhibition of monoamine oxidase A by alternariol monomethyl ether isolated from Alternaria brassicae. J Microbiol Biotechnol 27(2):316\u2013320. https:\/\/doi.org\/10.4014\/jmb.1610.10053","journal-title":"J Microbiol Biotechnol"},{"issue":"7","key":"3994_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/toxins8070191","volume":"8","author":"F Malir","year":"2016","unstructured":"Malir F, Ostry V, Pfohl-Leszkowicz A, Malir J, Toman J (2016) Ochratoxin A: 50 years of research. Toxins 8(7):191. https:\/\/doi.org\/10.3390\/toxins8070191","journal-title":"Toxins"},{"issue":"5","key":"3994_CR41","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3390\/toxins2051100","volume":"2","author":"PG Mantle","year":"2010","unstructured":"Mantle PG, Nolan CC (2010) Pathological outcomes in kidney and brain in male Fischer rats given dietary ochratoxin A, commencing at one year of age. Toxins 2(5):1100\u20131110. https:\/\/doi.org\/10.3390\/toxins2051100","journal-title":"Toxins"},{"issue":"7","key":"3994_CR71","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1038\/cddis.2012.94","volume":"3","author":"O Marques","year":"2012","unstructured":"Marques O, Outeiro TF (2012) Alpha-synuclein: from secretion to dysfunction and death. Cell Death Dis 3(7):e350. https:\/\/doi.org\/10.1038\/cddis.2012.94","journal-title":"Cell Death Dis"},{"issue":"9","key":"3994_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/toxins14090624","volume":"14","author":"E Mateo","year":"2022","unstructured":"Mateo E, Tonino RPB, Canto A, Monroy Noyola A, Miranda M, Soria JM, Garcia Esparza MA (2022) The neurotoxic effect of ochratoxin-A on the hippocampal neurogenic niche of adult mouse brain. Toxins 14(9):1\u201313. https:\/\/doi.org\/10.3390\/toxins14090624","journal-title":"Toxins"},{"issue":"4","key":"3994_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10048-011-0294-5","volume":"12","author":"GJ Michael","year":"2011","unstructured":"Michael GJ, Esmailzadeh S, Moran LB, Christian L, Pearce RKB, Graeber MB (2011) Up-regulation of metallothionein gene expression in Parkinsonian astrocytes. Neurogenetics 12(4):295\u2013305. https:\/\/doi.org\/10.1007\/s10048-011-0294-5","journal-title":"Neurogenetics"},{"issue":"1\u20132","key":"3994_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0165-3806(94)90168-6","volume":"82","author":"T Miki","year":"1994","unstructured":"Miki T, Fukui Y, Uemura N, Takeuchi Y (1994) Regional difference in the neurotoxicity of ochratoxin A on the developing cerebral cortex in mice. Brain Res Dev Brain Res 82(1\u20132):259\u2013264. https:\/\/doi.org\/10.1016\/0165-3806(94)90168-6","journal-title":"Brain Res Dev Brain Res"},{"issue":"2","key":"3994_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","volume":"197","author":"J Miklossy","year":"2006","unstructured":"Miklossy J, Doudet DD, Schwab C, Yu S, McGeer EG, McGeer PL (2006) Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Exp Neurol 197(2):275\u2013283. https:\/\/doi.org\/10.1016\/j.expneurol.2005.10.034","journal-title":"Exp Neurol"},{"issue":"3","key":"3994_CR46","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/glia.21112","volume":"59","author":"I Miyazaki","year":"2011","unstructured":"Miyazaki I, Asanuma M, Kikkawa Y, Takeshima M, Murakami S, Miyoshi K, Sogawa N, Kita T (2011) Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity. Glia 59(3):435\u2013451. https:\/\/doi.org\/10.1002\/glia.21112","journal-title":"Glia"},{"issue":"4","key":"3994_CR74","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/0960327107074589","volume":"26","author":"F Monnet-Tschudi","year":"2007","unstructured":"Monnet-Tschudi F, Zurich MG, Honegger P (2007) Neurotoxicant-induced inflammatory response in three-dimensional brain cell cultures. Human Exp Toxicol 26(4):339\u2013346. https:\/\/doi.org\/10.1177\/0960327107074589","journal-title":"Human Exp Toxicol"},{"key":"3994_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.toxrep.2019.11.015","volume":"7","author":"QA Nogaim","year":"2020","unstructured":"Nogaim QA, Sai Pratyusha Bugata L, Prabhakar PV, Reddy UA, Mangala Gowri P, InduKumari S, Mahboob M (2020) Protective effect of Yemeni green coffee powder against the oxidative stress induced by Ochratoxin A. Toxicol Rep 7:142\u2013148. https:\/\/doi.org\/10.1016\/j.toxrep.2019.11.015","journal-title":"Toxicol Rep"},{"key":"3994_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2020.00031","author":"LA O\u2019Leary","year":"2020","unstructured":"O\u2019Leary LA, Davoli MA, Belliveau C, Tanti A, Ma JC, Farmer WT, Turecki G, Murai KK, Mechawar N (2020) Characterization of vimentin-immunoreactive astrocytes in the human brain. Front Neuroanat. https:\/\/doi.org\/10.3389\/fnana.2020.00031","journal-title":"Front Neuroanat"},{"issue":"2","key":"3994_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005) Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol 57(2):168\u2013175. https:\/\/doi.org\/10.1002\/ana.20338","journal-title":"Ann Neurol"},{"key":"3994_CR50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.toxlet.2019.05.021","volume":"313","author":"S Park","year":"2019","unstructured":"Park S, Lim W, You S, Song G (2019) Ochratoxin A exerts neurotoxicity in human astrocytes through mitochondria-dependent apoptosis and intracellular calcium overload. Toxicol Lett 313:42\u201349. https:\/\/doi.org\/10.1016\/j.toxlet.2019.05.021","journal-title":"Toxicol Lett"},{"key":"3994_CR51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.toxlet.2024.01.009","volume":"393","author":"R Penalva-Olcina","year":"2024","unstructured":"Penalva-Olcina R, Juan C, Fern\u00e1ndez-Franz\u00f3n M, Juan-Garc\u00eda A (2024) Involvement of pro-inflammatory mediators and cell cycle disruption in neuronal cells induced by gliotoxin and ochratoxin A after individual and combined exposure. Toxicol Lett 393:24\u201332. https:\/\/doi.org\/10.1016\/j.toxlet.2024.01.009","journal-title":"Toxicol Lett"},{"issue":"3","key":"3994_CR52","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/BF03032339","volume":"24","author":"M Raters","year":"2008","unstructured":"Raters M, Matissek R (2008) Thermal stability of aflatoxin B1 and ochratoxin A. Mycotoxin Res 24(3):130\u2013134. https:\/\/doi.org\/10.1007\/BF03032339","journal-title":"Mycotoxin Res"},{"issue":"5","key":"3994_CR53","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.neuro.2010.06.003","volume":"31","author":"H Razafimanjato","year":"2010","unstructured":"Razafimanjato H, Garmy N, Guo XJ, Varini K, Di Scala C, Di Pasquale E, Ta\u00efeb N, Maresca M (2010) The food-associated fungal neurotoxin ochratoxin A inhibits the absorption of glutamate by astrocytes through a decrease in cell surface expression of the excitatory amino-acid transporters GLAST and GLT-1. Neurotoxicology 31(5):475\u2013484. https:\/\/doi.org\/10.1016\/j.neuro.2010.06.003","journal-title":"Neurotoxicology"},{"issue":"9\u201310","key":"3994_CR54","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","volume":"26","author":"R Re","year":"1999","unstructured":"Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biol Med 26(9\u201310):1231\u20131237. https:\/\/doi.org\/10.1016\/S0891-5849(98)00315-3","journal-title":"Free Radical Biol Med"},{"issue":"6","key":"3994_CR72","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/ijms17060904","volume":"17","author":"S Sarkar","year":"2016","unstructured":"Sarkar S, Raymick J, Imam S (2016) Neuroprotective and therapeutic strategies against Parkinson\u2019s disease: recent perspectives. Int J Mol Sci 17(6):904. https:\/\/doi.org\/10.3390\/ijms17060904","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3994_CR55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuro.2005.07.004","volume":"27","author":"V Sava","year":"2006","unstructured":"Sava V, Reunova O, Velasquez A, Harbison R, S\u00e1nchez-Ramos J (2006a) Acute neurotoxic effects of the fungal metabolite ochratoxin-A. Neurotoxicology 27(1):82\u201392. https:\/\/doi.org\/10.1016\/j.neuro.2005.07.004","journal-title":"Neurotoxicology"},{"issue":"1","key":"3994_CR56","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jns.2006.06.006","volume":"249","author":"V Sava","year":"2006","unstructured":"Sava V, Reunova O, Velasquez A, Sanchez-Ramos J (2006b) Can low level exposure to ochratoxin-A cause parkinsonism? J Neurol Sci 249(1):68\u201375. https:\/\/doi.org\/10.1016\/j.jns.2006.06.006","journal-title":"J Neurol Sci"},{"key":"3994_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13030219","author":"G Schwerdt","year":"2021","unstructured":"Schwerdt G, Kopf M, Gekle M (2021) The impact of the nephrotoxin ochratoxin a on human renal cells studied by a novel co-culture model is influenced by the presence of fibroblasts. Toxins. https:\/\/doi.org\/10.3390\/toxins13030219","journal-title":"Toxins"},{"key":"3994_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2022.153376","volume":"483","author":"R Sharma","year":"2023","unstructured":"Sharma R, Gettings SM, Hazell G, Bourbia N (2023) In vitro study of ochratoxin A in the expression of genes associated with neuron survival and viability. Toxicology 483:153376. https:\/\/doi.org\/10.1016\/j.tox.2022.153376","journal-title":"Toxicology"},{"issue":"6","key":"3994_CR60","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/brain\/awm097","volume":"130","author":"TC Thannickal","year":"2007","unstructured":"Thannickal TC, Lai YY, Siegel JM (2007) Hypocretin (orexin) cell loss in Parkinson\u2019s disease. Brain 130(6):1586\u20131595. https:\/\/doi.org\/10.1093\/brain\/awm097","journal-title":"Brain"},{"issue":"8","key":"3994_CR61","doi-asserted-by":"publisher","first-page":"21144","DOI":"10.1007\/s11356-022-23692-4","volume":"30","author":"J Valadas","year":"2023","unstructured":"Valadas J, Sachett A, Marcon M, Bastos LM, Piato A (2023) Ochratoxin A induces locomotor impairment and oxidative imbalance in adult zebrafish. Environ Sci Pollut Res 30(8):21144\u201321155. https:\/\/doi.org\/10.1007\/s11356-022-23692-4","journal-title":"Environ Sci Pollut Res"},{"key":"3994_CR62","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.foodchem.2015.01.098","volume":"178","author":"A Vidal","year":"2015","unstructured":"Vidal A, Sanchis V, Ramos AJ, Mar\u00edn S (2015) Thermal stability and kinetics of degradation of deoxynivalenol, deoxynivalenol conjugates and ochratoxin A during baking of wheat bakery products. Food Chem 178:276\u2013286. https:\/\/doi.org\/10.1016\/j.foodchem.2015.01.098","journal-title":"Food Chem"},{"issue":"9","key":"3994_CR63","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley LA, Luk KC, Lee VM-Y (2014) Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite\u2013like aggregates. Nat Protoc 9(9):2135\u20132146. https:\/\/doi.org\/10.1038\/nprot.2014.143","journal-title":"Nat Protoc"},{"key":"3994_CR64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuro.2014.04.005","volume":"44","author":"JS Von Tobel","year":"2014","unstructured":"Von Tobel JS, Antinori P, Zurich MG, Rosset R, Aschner M, Gl\u00fcck F, Scherl A, Monnet-Tschudi F (2014) Repeated exposure to Ochratoxin A generates a neuroinflammatory response, characterized by neurodegenerative M1 microglial phenotype. Neurotoxicology 44:61\u201370. https:\/\/doi.org\/10.1016\/j.neuro.2014.04.005","journal-title":"Neurotoxicology"},{"issue":"5","key":"3994_CR65","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10517-023-05772-8","volume":"174","author":"DN Voronkov","year":"2023","unstructured":"Voronkov DN, Stavrovskaya AV, Potapov IA, Guschina AS, Olshanskiy AS (2023) Glial reaction in a neuroinflammatory model of Parkinson\u2019s disease. Bull Exp Biol Med 174(5):693\u2013698. https:\/\/doi.org\/10.1007\/s10517-023-05772-8","journal-title":"Bull Exp Biol Med"},{"issue":"4","key":"3994_CR66","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.neuro.2009.04.013","volume":"30","author":"S Yoon","year":"2009","unstructured":"Yoon S, Cong WT, Bang Y, Lee SN, Yoon CS, Kwack SJ, Kang TS, Lee KY, Choi JK, Choi HJ (2009) Proteome response to ochratoxin A-induced apoptotic cell death in mouse hippocampal HT22 cells. Neurotoxicology 30(4):666\u2013676. https:\/\/doi.org\/10.1016\/j.neuro.2009.04.013","journal-title":"Neurotoxicology"},{"issue":"2","key":"3994_CR67","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1515\/bchm3.1996.377.2.121","volume":"377","author":"T \u017dani\u0107-Grubi\u0161i\u0107","year":"1996","unstructured":"\u017dani\u0107-Grubi\u0161i\u0107 T, Santini A, Cepelak I, Barisic K, Juretic D, Pepeljnjak S (1996) Influence of ochratoxin A treatment on the activity of membrane bound enzymes in rat brain regions. Bio Chem Hoppe-Seyler 377(2):121\u2013128. https:\/\/doi.org\/10.1515\/bchm3.1996.377.2.121","journal-title":"Bio Chem Hoppe-Seyler"},{"issue":"1","key":"3994_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12263-008-0109-y","volume":"4","author":"X Zhang","year":"2009","unstructured":"Zhang X, Boesch-Saadatmandi C, Lou Y, Wolffram S, Huebbe P, Rimbach G (2009) Ochratoxin A induces apoptosis in neuronal cells. Genes Nutr 4(1):41\u201348. https:\/\/doi.org\/10.1007\/s12263-008-0109-y","journal-title":"Genes Nutr"},{"issue":"3","key":"3994_CR69","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.neuroscience.2005.04.030","volume":"134","author":"MG Zurich","year":"2005","unstructured":"Zurich MG, Lengacher S, Braissant O, Monnet-Tschudi F, Pellerin L, Honegger P (2005) Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin a in aggregating rat brain cell cultures. Neuroscience 134(3):771\u2013782. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.04.030","journal-title":"Neuroscience"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-03994-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-03994-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-03994-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T07:49:48Z","timestamp":1747468188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-03994-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3994"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-03994-5","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}